Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Cancer
Clinical trial register · Norway

Cancer Trials in Norway, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Norway and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1259 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1259
Studies in scope
all four open statuses
666
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
Oslo 8 Bergen 4 Trondheim 3 Tromsø 2 Stavanger 1
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Cancer trials in Norway

12 of 1259 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Norway
Start
Recruiting
Dexmedetomidine for Refractory Pain in Palliative Cancer Patients
NCT07885475Cancer, Palliative Care, Patient Care, Pain Management, Dexmedetomidine Analgesia
St. Olavs Hospital
Observational
30
Drammen, Oslo, Tromsø, Trondheim
2026-04-10
Not yet open
Haukeland University Hospital
Not applicable
60
Bergen
2025-01-02
Recruiting
Feasibility of Intermittent Fasting During Chemotherapy
NCT06645093Lymphoma, Cancer, Fasting
University of Oslo
Not applicable
40
Oslo
2024-10-31
Active, closed
Norwegian University of Science and Technology
Observational
160
Trondheim
2023-09-05
Active, closed
Inland Norway University of Applied Sciences
Not applicable
160
Gjøvik, Hamar, Lillehammer
2023-08-01
Recruiting
Lovisenberg Diakonale Hospital
Not applicable
150
Oslo
2023-03-30
Recruiting
Oslo University Hospital
Observational
200
Oslo
2020-06-01
Active, closed
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
NCT04392505Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage III, NSCLC
Oslo University Hospital
Phase 2
100
Bergen, Oslo, Stavanger, Tromsø, Trondheim
2020-05-11
Active, closed
Åslaug Helland
Phase 2
118
Oslo
2020-05-04
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bergen, Oslo
2019-08-09
Active, closed
Oslo University Hospital
Not applicable
200
Oslo
2016-10
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Bergen
2005-08
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Norwegian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-norway/condition/cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Norway and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,259 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Cancer.

How many Cancer trials are recruiting in Norway?

6 of the 12 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cancer), 12 studies
PhaseStudiesRecruitingShare
Not applicable5241.7%
Observational4333.3%
Phase 23125%

Most active sponsors

Lead sponsors with the most studies (Cancer)
Lead sponsorStudiesRecruiting
Oslo University Hospital31
Bristol-Myers Squibb11
Haukeland University Hospital10
Inland Norway University of Applied Sciences10
Lovisenberg Diakonale Hospital11
Norwegian University of Science and Technology10
St. Olavs Hospital11
University Hospital, Gasthuisberg11
University of Oslo11
Åslaug Helland10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.